| UniProt ID | AGM1_HUMAN | |
|---|---|---|
| UniProt AC | O95394 | |
| Protein Name | Phosphoacetylglucosamine mutase {ECO:0000305} | |
| Gene Name | PGM3 {ECO:0000312|HGNC:HGNC:8907} | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 542 | |
| Subcellular Localization | ||
| Protein Description | Catalyzes the conversion of GlcNAc-6-P into GlcNAc-1-P during the synthesis of uridine diphosphate/UDP-GlcNAc, a sugar nucleotide critical to multiple glycosylation pathways including protein N- and O-glycosylation.. | |
| Protein Sequence | MDLGAITKYSALHAKPNGLILQYGTAGFRTKAEHLDHVMFRMGLLAVLRSKQTKSTIGVMVTASHNPEEDNGVKLVDPLGEMLAPSWEEHATCLANAEEQDMQRVLIDISEKEAVNLQQDAFVVIGRDTRPSSEKLSQSVIDGVTVLGGQFHDYGLLTTPQLHYMVYCRNTGGRYGKATIEGYYQKLSKAFVELTKQASCSGDEYRSLKVDCANGIGALKLREMEHYFSQGLSVQLFNDGSKGKLNHLCGADFVKSHQKPPQGMEIKSNERCCSFDGDADRIVYYYHDADGHFHLIDGDKIATLISSFLKELLVEIGESLNIGVVQTAYANGSSTRYLEEVMKVPVYCTKTGVKHLHHKAQEFDIGVYFEANGHGTALFSTAVEMKIKQSAEQLEDKKRKAAKMLENIIDLFNQAAGDAISDMLVIEAILALKGLTVQQWDALYTDLPNRQLKVQVADRRVISTTDAERQAVTPPGLQEAINDLVKKYKLSRAFVRPSGTEDVVRVYAEADSQESADHLAHEVSLAVFQLAGGIGERPQPGF | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 1 | Acetylation | -------MDLGAITK -------CCCCHHCC | 9.65 | 22223895 | |
| 8 | Ubiquitination | MDLGAITKYSALHAK CCCCHHCCHHHHHCC | 30.97 | 21890473 | |
| 42 | Sulfoxidation | LDHVMFRMGLLAVLR HHHHHHHHHHHHHHH | 2.79 | 28465586 | |
| 50 | Phosphorylation | GLLAVLRSKQTKSTI HHHHHHHCCCCCCEE | 25.59 | 28985074 | |
| 55 | Phosphorylation | LRSKQTKSTIGVMVT HHCCCCCCEEEEEEE | 28.75 | 23927012 | |
| 56 | Phosphorylation | RSKQTKSTIGVMVTA HCCCCCCEEEEEEEC | 24.25 | 23927012 | |
| 60 | Oxidation | TKSTIGVMVTASHNP CCCEEEEEEECCCCC | 1.54 | 17322306 | |
| 62 | Phosphorylation | STIGVMVTASHNPEE CEEEEEEECCCCCCC | 12.35 | 22167270 | |
| 64 | Phosphorylation | IGVMVTASHNPEEDN EEEEEECCCCCCCCC | 17.90 | 29255136 | |
| 86 | Phosphorylation | LGEMLAPSWEEHATC CHHCCCCCHHHHHHH | 41.32 | 30206219 | |
| 92 | Phosphorylation | PSWEEHATCLANAEE CCHHHHHHHHHCCCH | 15.23 | 30206219 | |
| 110 | Phosphorylation | QRVLIDISEKEAVNL HHEEEECCHHHHCCC | 38.58 | 29759185 | |
| 177 | Ubiquitination | NTGGRYGKATIEGYY CCCCCCCEEEHHHHH | 33.16 | - | |
| 177 | Malonylation | NTGGRYGKATIEGYY CCCCCCCEEEHHHHH | 33.16 | 26320211 | |
| 186 | Ubiquitination | TIEGYYQKLSKAFVE EHHHHHHHHHHHHHH | 38.31 | - | |
| 189 | Ubiquitination | GYYQKLSKAFVELTK HHHHHHHHHHHHHHH | 57.17 | 1890473 | |
| 196 | Ubiquitination | KAFVELTKQASCSGD HHHHHHHHHCCCCCC | 57.39 | - | |
| 199 | Phosphorylation | VELTKQASCSGDEYR HHHHHHCCCCCCCCC | 13.30 | 30624053 | |
| 205 (in isoform 1) | Ubiquitination | - | 15.39 | 21906983 | |
| 209 | Acetylation | GDEYRSLKVDCANGI CCCCCCCEEECCCCC | 36.96 | 26051181 | |
| 209 | Ubiquitination | GDEYRSLKVDCANGI CCCCCCCEEECCCCC | 36.96 | - | |
| 217 (in isoform 1) | Ubiquitination | - | 26.67 | 21906983 | |
| 220 | Ubiquitination | ANGIGALKLREMEHY CCCCCHHHHHHHHHH | 44.99 | - | |
| 244 | Acetylation | FNDGSKGKLNHLCGA ECCCCCCCHHHHCCC | 50.26 | 25953088 | |
| 244 | Ubiquitination | FNDGSKGKLNHLCGA ECCCCCCCHHHHCCC | 50.26 | - | |
| 255 | Ubiquitination | LCGADFVKSHQKPPQ HCCCCHHHHCCCCCC | 42.06 | - | |
| 259 | Ubiquitination | DFVKSHQKPPQGMEI CHHHHCCCCCCCCEE | 53.92 | - | |
| 264 | Sulfoxidation | HQKPPQGMEIKSNER CCCCCCCCEECCCCC | 3.97 | 30846556 | |
| 267 | Ubiquitination | PPQGMEIKSNERCCS CCCCCEECCCCCEEC | 33.64 | - | |
| 307 | Phosphorylation | KIATLISSFLKELLV HHHHHHHHHHHHHHH | 27.83 | 24719451 | |
| 319 | Phosphorylation | LLVEIGESLNIGVVQ HHHHHHHHCCEEEEE | 22.85 | 24719451 | |
| 327 | Phosphorylation | LNIGVVQTAYANGSS CCEEEEEEEECCCCC | 15.27 | 23828894 | |
| 343 | Ubiquitination | RYLEEVMKVPVYCTK HHHHHHHCCCEEECC | 48.87 | - | |
| 347 | Phosphorylation | EVMKVPVYCTKTGVK HHHCCCEEECCCCCC | 6.58 | 24719451 | |
| 349 | Phosphorylation | MKVPVYCTKTGVKHL HCCCEEECCCCCCCC | 17.60 | - | |
| 350 | Ubiquitination | KVPVYCTKTGVKHLH CCCEEECCCCCCCCC | 39.46 | - | |
| 350 | Malonylation | KVPVYCTKTGVKHLH CCCEEECCCCCCCCC | 39.46 | 26320211 | |
| 350 | Acetylation | KVPVYCTKTGVKHLH CCCEEECCCCCCCCC | 39.46 | 25953088 | |
| 354 | Ubiquitination | YCTKTGVKHLHHKAQ EECCCCCCCCCCCCC | 41.62 | - | |
| 376 | Phosphorylation | FEANGHGTALFSTAV EEECCCCEEEHHHHH | 17.95 | - | |
| 388 | Ubiquitination | TAVEMKIKQSAEQLE HHHHHHHHHHHHHHH | 32.45 | 21906983 | |
| 397 | Ubiquitination | SAEQLEDKKRKAAKM HHHHHHHHHHHHHHH | 45.14 | 2190698 | |
| 398 | Acetylation | AEQLEDKKRKAAKML HHHHHHHHHHHHHHH | 72.03 | 7481271 | |
| 416 (in isoform 1) | Ubiquitination | - | 13.46 | 21906983 | |
| 425 (in isoform 1) | Ubiquitination | - | 2.74 | 21906983 | |
| 453 | Ubiquitination | DLPNRQLKVQVADRR CCCCCEEEEEEECCE | 23.45 | - | |
| 453 | Acetylation | DLPNRQLKVQVADRR CCCCCEEEEEEECCE | 23.45 | 25953088 | |
| 453 | Malonylation | DLPNRQLKVQVADRR CCCCCEEEEEEECCE | 23.45 | 26320211 | |
| 463 | Phosphorylation | VADRRVISTTDAERQ EECCEEECCCHHHHH | 23.54 | 20068231 | |
| 464 | Phosphorylation | ADRRVISTTDAERQA ECCEEECCCHHHHHC | 19.99 | 20068231 | |
| 465 | Phosphorylation | DRRVISTTDAERQAV CCEEECCCHHHHHCC | 26.82 | 20068231 | |
| 498 | Phosphorylation | SRAFVRPSGTEDVVR CCEECCCCCCCCEEE | 48.02 | 27050516 | |
| 500 | Phosphorylation | AFVRPSGTEDVVRVY EECCCCCCCCEEEEE | 33.09 | 23186163 | |
| 526 | Phosphorylation | LAHEVSLAVFQLAGG HHHHHHHHHHHHCCC | 7.80 | 24719451 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of AGM1_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of AGM1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of AGM1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| A4_HUMAN | APP | physical | 21832049 | |
| ENOPH_HUMAN | ENOPH1 | physical | 26344197 | |
| HDHD1_HUMAN | HDHD1 | physical | 26344197 | |
| LACB2_HUMAN | LACTB2 | physical | 26344197 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 615816 | Immunodeficiency 23 (IMD23) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-64, AND MASSSPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-64, AND MASSSPECTROMETRY. | |